These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

222 related items for PubMed ID: 17336708

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Monitoring biological action of rapamycin in renal transplantation.
    Leogrande D, Teutonico A, Ranieri E, Saldarelli M, Gesualdo L, Schena FP, Di Paolo S.
    Am J Kidney Dis; 2007 Aug; 50(2):314-25. PubMed ID: 17660033
    [Abstract] [Full Text] [Related]

  • 4. Ultraviolet-induced phosphorylation of p70(S6K) at Thr(389) and Thr(421)/Ser(424) involves hydrogen peroxide and mammalian target of rapamycin but not Akt and atypical protein kinase C.
    Huang C, Li J, Ke Q, Leonard SS, Jiang BH, Zhong XS, Costa M, Castranova V, Shi X.
    Cancer Res; 2002 Oct 15; 62(20):5689-97. PubMed ID: 12384526
    [Abstract] [Full Text] [Related]

  • 5. Sirolimus for Kaposi's sarcoma in renal-transplant recipients.
    Stallone G, Schena A, Infante B, Di Paolo S, Loverre A, Maggio G, Ranieri E, Gesualdo L, Schena FP, Grandaliano G.
    N Engl J Med; 2005 Mar 31; 352(13):1317-23. PubMed ID: 15800227
    [Abstract] [Full Text] [Related]

  • 6. Phosphorylation of ribosomal p70 S6 kinase and rapamycin sensitivity in human colorectal cancer.
    Nozawa H, Watanabe T, Nagawa H.
    Cancer Lett; 2007 Jun 18; 251(1):105-13. PubMed ID: 17175097
    [Abstract] [Full Text] [Related]

  • 7. Pharmacodynamic Evaluation of CCI-779, an Inhibitor of mTOR, in Cancer Patients.
    Peralba JM, DeGraffenried L, Friedrichs W, Fulcher L, Grünwald V, Weiss G, Hidalgo M.
    Clin Cancer Res; 2003 Aug 01; 9(8):2887-92. PubMed ID: 12912932
    [Abstract] [Full Text] [Related]

  • 8. The Akt/mammalian target of rapamycin signal transduction pathway is activated in high-risk myelodysplastic syndromes and influences cell survival and proliferation.
    Follo MY, Mongiorgi S, Bosi C, Cappellini A, Finelli C, Chiarini F, Papa V, Libra M, Martinelli G, Cocco L, Martelli AM.
    Cancer Res; 2007 May 01; 67(9):4287-94. PubMed ID: 17483341
    [Abstract] [Full Text] [Related]

  • 9. Morphoproteomic and molecular concomitants of an overexpressed and activated mTOR pathway in renal cell carcinomas.
    Lin F, Zhang PL, Yang XJ, Prichard JW, Lun M, Brown RE.
    Ann Clin Lab Sci; 2006 May 01; 36(3):283-93. PubMed ID: 16951269
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Maximal lengthening contractions increase p70 S6 kinase phosphorylation in human skeletal muscle in the absence of nutritional supply.
    Eliasson J, Elfegoun T, Nilsson J, Köhnke R, Ekblom B, Blomstrand E.
    Am J Physiol Endocrinol Metab; 2006 Dec 01; 291(6):E1197-205. PubMed ID: 16835402
    [Abstract] [Full Text] [Related]

  • 13. Chronic inhibition of mammalian target of rapamycin signaling downregulates insulin receptor substrates 1 and 2 and AKT activation: A crossroad between cancer and diabetes?
    Di Paolo S, Teutonico A, Leogrande D, Capobianco C, Schena PF.
    J Am Soc Nephrol; 2006 Aug 01; 17(8):2236-44. PubMed ID: 16807405
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Combination of rapamycin and 17-allylamino-17-demethoxygeldanamycin abrogates Akt activation and potentiates mTOR blockade in breast cancer cells.
    Roforth MM, Tan C.
    Anticancer Drugs; 2008 Aug 01; 19(7):681-8. PubMed ID: 18594209
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Noradrenaline enhances the expression of the neuronal monocarboxylate transporter MCT2 by translational activation via stimulation of PI3K/Akt and the mTOR/S6K pathway.
    Chenal J, Pellerin L.
    J Neurochem; 2007 Jul 01; 102(2):389-97. PubMed ID: 17394554
    [Abstract] [Full Text] [Related]

  • 18. Changes in signalling pathways regulating protein synthesis in human muscle in the recovery period after endurance exercise.
    Mascher H, Andersson H, Nilsson PA, Ekblom B, Blomstrand E.
    Acta Physiol (Oxf); 2007 Sep 01; 191(1):67-75. PubMed ID: 17488244
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The biology behind mTOR inhibition in sarcoma.
    Wan X, Helman LJ.
    Oncologist; 2007 Aug 01; 12(8):1007-18. PubMed ID: 17766661
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.